Feinle C, D'Amato M, Read N W
Centre for Human Nutrition, Northern General Hospital, Sheffield, England.
Gastroenterology. 1996 May;110(5):1379-85. doi: 10.1053/gast.1996.v110.pm8613041.
BACKGROUND & AIMS: The combination of duodenal lipid and gastric distention induces meal-like fullness followed by nausea in healthy subjects. The aim of this study was to assess the role of cholecystokinin (CCK) A receptors in these changes using a CCK-A antagonist loxiglumide.
Twelve healthy subjects were studied on four occasions, during which either 0.9% saline or 20% Intralipid was infused intraduodenally on two occasions each (1 mL/min) while the proximal stomach was distended with air (100 mL/min). During each duodenal infusion, subjects received intravenous loxiglumide (10 mg.kg-1.h-1) on 1 day and placebo on the other. Intragastric pressure changes were recorded, and the subjects reported gastric sensations (fullness, nausea).
Loxiglumide did not influence gastric motility or sensitivity during duodenal saline infusion. Duodenal lipid reduced gastric tonic and phasic pressure activity during distensions and induced meal-like fullness and nausea; sensations were reported at similar volumes but lower intragastric pressures (P < 0.001 vs. saline). Loxiglumide partially restored gastric tonic and phasic activity during lipid infusion, reduced the occurrence of meal-like fullness and nausea, and increased the pressures at which sensations were reported (P < 0.001 vs. placebo).
CCK-A receptors are involved in the induction of meal-like fullness and nausea associated with intraduodenal lipid and gastric distention.
十二指肠内脂质与胃扩张相结合可使健康受试者产生类似进餐的饱腹感,随后出现恶心感。本研究旨在使用胆囊收缩素(CCK)A受体拮抗剂洛昔咯米特评估CCK-A受体在这些变化中的作用。
对12名健康受试者进行了4次研究,期间分别在两种情况下十二指肠内输注0.9%生理盐水或20%英脱利匹特(各1 mL/分钟),同时用空气使胃近端扩张(100 mL/分钟)。在每次十二指肠输注期间,受试者在1天接受静脉注射洛昔咯米特(10 mg·kg-1·h-1),另一天接受安慰剂。记录胃内压变化,受试者报告胃部感觉(饱腹感、恶心感)。
在十二指肠输注生理盐水期间,洛昔咯米特不影响胃动力或敏感性。十二指肠内脂质在扩张期间降低了胃的紧张性和相性压力活动,并诱发了类似进餐的饱腹感和恶心感;在相似容量但较低胃内压时报告有这些感觉(与生理盐水相比,P < 0.001)。洛昔咯米特在脂质输注期间部分恢复了胃的紧张性和相性活动,减少了类似进餐的饱腹感和恶心感的发生,并提高了报告有感觉时的压力(与安慰剂相比,P < 0.001)。
CCK-A受体参与了与十二指肠内脂质和胃扩张相关的类似进餐的饱腹感和恶心感的诱发过程。